Need for Raising Awareness - Monitoring Urinary Protein Excretion in Cardiac Transplant Patients Receiving Mammalian Target of Rapamycin Inhibitors.
Division of Nephrology, Hypertension, and Renal Transplantation, University of Florida, Gainesville, Fla., USA.
Negiin
N
Pourafshar
Ashkan
A
Karimi
Jon
J
Gregg
Amir
A
Kazory
D000068338:Everolimus / Q000009:adverse effects; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D011507:Proteinuria / Q000139:chemically induced*; D012307:Risk Factors; D020123:Sirolimus / Q000009:adverse effects; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*
D007166:Immunosuppressive Agents; D000068338:Everolimus; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus